Clinical trial
Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or…
NCT00002688 · University Medical Center Groningen, Other · Unknown status
Key facts
| NCT number | NCT00002688 |
|---|---|
| Title | Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia |
| Official title | AML-MVPCYA: ADDITION OF CYCLOSPORIN A TO THE COMBINATION OF MITOXANTRONE AND ETOPOSIDE (VP 16,213) TO OVERCOME RESISTANCE TO CHEMOTHERAPY IN REFRACTORY AML: A RANDOMIZED PHASE II STUDY |
| Lead sponsor | University Medical Center Groningen, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | cyclosporine, etoposide, mitoxantrone hydrochloride |
| Enrollment | 25 |
| Start date | Feb 1, 1995 |
| First posted | Jul 29, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | Belgium, Netherlands, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: